M-C-G wrote:ACB - Aurora
I was looking through the conversation on Yahoo, some times there is a lot of nutty stuff, but I found this interesting and kind of in line with the potential growth of the industry as a wholeAurora's 2017 3rd quarter profits of $8 million were from only 1,009,585 grams, or 1,009 kg. In the near future (2yrs) Aurora's current projects and acquisitions should be completed and be producing over 200,000 kg yearly or 50,000 quarterly. 50 times more cannabis than what is currently being produced. Assuming there's around 700,000,000 shares outstanding 2 years from now and $1.6 billion in yearly profit, $2.28 earnings per share, a PE ratio of 30, the stock price should be $68.50 if all the numbers come true. Also, there's going to be many more projects and acquisitions announced in the next 2 years. I hope to get a few responses.
Aurora makes up 6.7% of MJX along with Cronos, Canopy and MedReleaf...if those other companies see remotely any kind of similar growth, I would assume MJX is going to be a really nice long term play.
Hard to believe there's that kind of demand and it's elastic enough to justify that much production. That is, unless Dylan was right all along.
























